StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) stock

EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$134.93−2.95 (-2.14%)

Close on Nov 18, 2026Market cap $13.31BP/E 22.0Yield 0.53%

Encompass Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Encompass Health's revenue for the twelve months ending Jun 30, 2026 was $6.21B, up 9.5% year over year. For fiscal 2025 it was $5.94B, up 10.5% from the year before. The highest annual figure on record is $5.94B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.94B+10.5%
FY2024Dec 31, 2024$5.37B+11.9%
FY2023Dec 31, 2023$4.80B+10.4%
FY2022Dec 31, 2022$4.35B+8.3%
FY2021Dec 31, 2021$4.01B+12.6%
FY2020Dec 31, 2020$3.57B-22.6%
FY2019Dec 31, 2019$4.61B+7.7%
FY2018Dec 31, 2018$4.28B+9.3%
FY2017Dec 31, 2017$3.91B+7.4%
FY2016Dec 31, 2016$3.64B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.60B+9.6%
Q1 FY2026Mar 31, 2026$1.59B+9.0%
Q4 FY2025Dec 31, 2025$1.54B+9.9%
Q3 FY2025Sep 30, 2025$1.48B+9.4%
Q2 FY2025Jun 30, 2025$1.46B+12.0%
Q1 FY2025Mar 31, 2025$1.46B+10.6%
Q4 FY2024Dec 31, 2024$1.41B+12.7%
Q3 FY2024Sep 30, 2024$1.35B+11.9%
Q2 FY2024Jun 30, 2024$1.30B+9.6%
Q1 FY2024Mar 31, 2024$1.32B+13.4%
Q4 FY2023Dec 31, 2023$1.25B+9.6%
Q3 FY2023Sep 30, 2023$1.21B+10.8%
Q2 FY2023Jun 30, 2023$1.19B+11.7%
Q1 FY2023Mar 31, 2023$1.16B+9.5%
Q4 FY2022Dec 31, 2022$1.14B+9.1%
Q3 FY2022Sep 30, 2022$1.09B+7.8%
Q2 FY2022Jun 30, 2022$1.06B+6.1%
Q1 FY2022Mar 31, 2022$1.06B+10.4%
Q4 FY2021Dec 31, 2021$1.04B-14.2%
Q3 FY2021Sep 30, 2021$1.01B-13.9%
Q2 FY2021Jun 30, 2021$1.00B-6.7%
Q1 FY2021Mar 31, 2021$959.90M-18.8%
Q4 FY2020Dec 31, 2020$1.21B+2.5%
Q3 FY2020Sep 30, 2020$1.17B+1.1%
Q2 FY2020Jun 30, 2020$1.07B-5.4%
Q1 FY2020Mar 31, 2020$1.18B+5.2%
Q4 FY2019Dec 31, 2019$1.18B+8.1%
Q3 FY2019Sep 30, 2019$1.16B+8.8%
Q2 FY2019Jun 30, 2019$1.14B+6.3%
Q1 FY2019Mar 31, 2019$1.12B+7.5%
Q4 FY2018Dec 31, 2018$1.10B+8.6%
Q3 FY2018Sep 30, 2018$1.07B+8.8%
Q2 FY2018Jun 30, 2018$1.07B+10.5%
Q1 FY2018Mar 31, 2018$1.05B+9.3%
Q4 FY2017Dec 31, 2017$1.01B–
Q3 FY2017Sep 30, 2017$981.60M–
Q2 FY2017Jun 30, 2017$966.40M–
Q1 FY2017Mar 31, 2017$957.10M–

More Encompass Health figures

See a number that looks wrong?